August 29, 2016 5:02 AM ET

Biotechnology

Company Overview of Innate Pharma S.A.

Executive Profile

Philip D. Greenberg M.D.

Member of the Scientific Advisory Board, Innate Pharma S.A.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 8 different industries.

See Board Relationships
----

Background

Prof. Dr. Philip D. Greenberg, also known as Phil, M.D. serves as the Head of Program in Immunology at Fred Hutchinson Cancer Research Center. Prof. Greenberg is a Professor of Medicine in Oncology and Immunology at University of Washington. He is the scientific co-founder of Juno Therapeutics. Prof. Greenberg served as Director of the Immunology Program at FHCRC and Co-Director of the Immunology Program for UW Center for AIDS Research since 1988. He joined FHCRC and ...

Corporate Headquarters

117 Avenue de Luminy
Marseille, Provence-Alpes-Côte d'Azur 13009

France

Phone: 33 4 30 30 30 30
Fax: 33 4 30 30 30 00

Board Members Memberships

Director

Education

MD 1971
State University of New York
Unknown/Other Education
Washington University, St. Louis
Post-Doctoral Training
University of California - San Diego

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Innate Pharma S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.